- Author:
Na-Na ZHANG
1
;
Zi-Jian LI
2
;
Hai-Bo ZHU
3
Author Information
- Publication Type:Journal Article
- Keywords: coronary artery disease; higenamine; myocardial perfusion imaging; stress agent
- MeSH: Humans; Coronary Artery Disease; Myocardial Perfusion Imaging/methods*; Tetrahydroisoquinolines; Alkaloids; Coronary Angiography/methods*
- From: Chinese Medical Sciences Journal 2022;37(3):275-281
- CountryChina
- Language:English
- Abstract: Myocardial perfusion imaging (MPI) is valuable for the diagnosis, prognosis, and management of coronary artery disease (CAD). The most commonly used pharmacologic stress agents at present are vasodilators and adrenergic agents. However, these agents have contraindications and may cause adverse effects in some patients. Thus, other stress agents feasible for more patients are required. Higenamine (HG) is a β-adrenergic receptor agonist currently approved for clinical trials as a stress agent for myocardial infarction. It also has a promising value in MPI for the detection of CAD in preclinical and clinical studies. This review summarizes the application of HG on MPI, including its mechanism of action, stress protocol, efficacy, and safety.